Endovascular repair of common femoral artery and concomitant arterial lesions

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 6, 2011, Pages 787-793

  Azema L ^a   Davaine, J M ^a   Guyomarch, B ^a   Chaillou, P ^a   Costargent, A ^a   Patra, P ^a   Goueffic Y ^a  

^a L INSTITUT DU THORAX   (France)

Author keywords

Angioplasty; Femoral artery; Peripheral artery disease; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANASTOMOSIS; ARTERY LESION; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ENDOVASCULAR SURGERY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; LIMB ISCHEMIA; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVASCULARIZATION; STENT; SURGICAL APPROACH; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; COHORT STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 79955969332     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.02.025     Document Type: Article

References (21)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45(Suppl. S):S5-67.
2. Cardon A, Aillet S, Jarno P, Bensalah K, Le Du J, Idrissi A, et al. Endarteriectomy of the femoral tripod: long-term results and analysis of failure factors. Ann Chir 2001;126(8):777-82. (Pubitemid 32964120)
3. Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg 2008;48(4):872-7.
4. Kechagias A, Ylonen K, Biancari F. Long-term outcome after isolated endarterectomy of the femoral bifurcation. World J Surg 2008;32(1):51-4. (Pubitemid 50004249)
5. Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radiol 1999;10(9):1219-28. (Pubitemid 29480942)
6. Ballard JL, Sparks SR, Taylor FC, Bergan JJ, Smith DC, Bunt TJ, et al. Complications of iliac artery stent deployment. J Vasc Surg 1996;24(4):545-53. discussion 53-5.
7. Lopez JF, Magne JL, Champetier J. The femoral artery and flexion of the hip joint. Surg Radiol Anat 1989;11(4):275-81. (Pubitemid 20003502)
8. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation 2007;116(18):2072-85. (Pubitemid 350027514)
9. Silva JA, White CJ, Quintana H, Collins TJ, Jenkins JS, Ramee SR. Percutaneous revascularization of the common femoral artery for limb ischemia. Catheter Cardiovasc Interv 2004;62(2):230-3. (Pubitemid 38788704)
10. Stricker H, Jacomella V. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: midterm outcomes. J Endovasc Ther 2004;11(3):281-6. (Pubitemid 38802610)
11. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99(1):44-52. (Pubitemid 29035956)
12. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348(9038):1329-39.
13. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3(3):267-76.
14. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354(18):1879-88. (Pubitemid 43872689)
15. Diehm N, Pattynama PM, Jaff MR, Cremonesi A, Becker GJ, Hopkins LN, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg 2008;36(4):409-19.
16. Ranke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander K. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound 1992;20(3):187-93.
17. Jaff M, Dake M, Pompa J, Ansel G, Yoder T. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Catheter Cardiovasc Interv 2007;70(3):460-2. (Pubitemid 350194998)
18. Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year singlecenter prospective study. Surgery 2010;147(2):268-74.
19. Mukherjee D, Inahara T. Endarterectomy as the procedure of choice for atherosclerotic occlusive lesions of the common femoral artery. Am J Surg 1989;157(5):498-500. (Pubitemid 19127467)
20. Springhorn ME, Kinney M, Littooy FN, Saletta C, Greisler HP. Inflow atherosclerotic disease localized to the common femoral artery: treatment and outcome. Ann Vasc Surg 1991;5(3):234-40.
21. Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 2008;36(3):339-45.